The transfusion of human convalescent plasma as a mitigation and treatment option for patients with COVID-19 is associated with a low rate of serious adverse events.
Individuals who smoke and experience sleep disturbances are less likely to quit smoking.
The patient, a 74-year-old female, presented to the ER after experiencing a low grade fever, cough, and shortness of breath for 2 days.
The FDA has granted Orphan Drug designation to INO-3107, a DNA plasmid immunotherapy, for the treatment of recurrent respiratory papillomatosis, a rare disease caused by human papillomavirus types 6 and 11 infections.
Critically ill patients hospitalized with COVID-19 — particularly those who develop ARDS — may also experience an opportunistic aspergillosis superinfection.
Although bacterial and fungal infections appear to be uncommon in patients hospitalized with COVID-19, many patients received antibiotics during their hospitalization.
Changes in Radiographic Assessment of Lung Edema (RALE) scores in patients with ARDS were independently associated with survival.
A coronary angiography was performed in the prone position in a patient with ARDS related to COVID-19, in an effort to maintain reasonable oxygen saturation.